vs

Side-by-side financial comparison of Liberty Broadband Corp (LBRDA) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

Liberty Broadband Corp is the larger business by last-quarter revenue ($261.0M vs $142.0M, roughly 1.8× Oncology Institute, Inc.). Liberty Broadband Corp runs the higher net margin — 146.7% vs -5.3%, a 152.0% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs 6.1%). Liberty Broadband Corp produced more free cash flow last quarter ($37.0M vs $2.2M). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs 4.3%).

Liberty Global Ltd. is a British-Dutch-American multinational telecommunications company domiciled in Bermuda, with headquarters in London, Amsterdam and Denver. Its respective legal names are Liberty Global Holdings Limited (UK), Liberty Global B.V. (Netherlands) and Liberty Global, Inc., with the first of these being publicly traded. It was formed in 2005 by the merger of the international arm of Liberty Media and UnitedGlobalCom (UGC).

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

LBRDA vs TOI — Head-to-Head

Bigger by revenue
LBRDA
LBRDA
1.8× larger
LBRDA
$261.0M
$142.0M
TOI
Growing faster (revenue YoY)
TOI
TOI
+35.5% gap
TOI
41.6%
6.1%
LBRDA
Higher net margin
LBRDA
LBRDA
152.0% more per $
LBRDA
146.7%
-5.3%
TOI
More free cash flow
LBRDA
LBRDA
$34.8M more FCF
LBRDA
$37.0M
$2.2M
TOI
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
4.3%
LBRDA

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
LBRDA
LBRDA
TOI
TOI
Revenue
$261.0M
$142.0M
Net Profit
$383.0M
$-7.5M
Gross Margin
Operating Margin
15.7%
-4.9%
Net Margin
146.7%
-5.3%
Revenue YoY
6.1%
41.6%
Net Profit YoY
96.4%
43.0%
EPS (diluted)
$2.68
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LBRDA
LBRDA
TOI
TOI
Q4 25
$142.0M
Q3 25
$136.6M
Q2 25
$261.0M
$119.8M
Q1 25
$266.0M
$104.4M
Q4 24
$263.0M
$100.3M
Q3 24
$262.0M
$99.9M
Q2 24
$246.0M
$98.6M
Q1 24
$245.0M
$94.7M
Net Profit
LBRDA
LBRDA
TOI
TOI
Q4 25
$-7.5M
Q3 25
$-16.5M
Q2 25
$383.0M
$-17.0M
Q1 25
$268.0M
$-19.6M
Q4 24
$291.0M
$-13.2M
Q3 24
$142.0M
$-16.1M
Q2 24
$195.0M
$-15.5M
Q1 24
$241.0M
$-19.9M
Operating Margin
LBRDA
LBRDA
TOI
TOI
Q4 25
-4.9%
Q3 25
-5.9%
Q2 25
15.7%
-9.4%
Q1 25
16.2%
-9.5%
Q4 24
4.9%
-11.9%
Q3 24
11.5%
-13.9%
Q2 24
8.5%
-16.6%
Q1 24
11.4%
-19.0%
Net Margin
LBRDA
LBRDA
TOI
TOI
Q4 25
-5.3%
Q3 25
-12.1%
Q2 25
146.7%
-14.2%
Q1 25
100.8%
-18.8%
Q4 24
110.6%
-13.1%
Q3 24
54.2%
-16.1%
Q2 24
79.3%
-15.7%
Q1 24
98.4%
-21.0%
EPS (diluted)
LBRDA
LBRDA
TOI
TOI
Q4 25
$-0.04
Q3 25
$-0.14
Q2 25
$2.68
$-0.15
Q1 25
$1.87
$-0.21
Q4 24
$2.04
$-0.14
Q3 24
$0.99
$-0.18
Q2 24
$1.36
$-0.17
Q1 24
$1.69
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LBRDA
LBRDA
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$180.0M
Total DebtLower is stronger
$3.1B
Stockholders' EquityBook value
$10.4B
$-15.7M
Total Assets
$16.6B
$164.7M
Debt / EquityLower = less leverage
0.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LBRDA
LBRDA
TOI
TOI
Q4 25
Q3 25
Q2 25
$180.0M
Q1 25
$226.0M
Q4 24
$163.0M
Q3 24
$168.0M
Q2 24
$73.0M
$9.9M
Q1 24
$108.0M
$29.8M
Total Debt
LBRDA
LBRDA
TOI
TOI
Q4 25
Q3 25
Q2 25
$3.1B
Q1 25
$3.8B
Q4 24
$3.8B
Q3 24
$3.7B
Q2 24
$3.6B
Q1 24
$3.6B
Stockholders' Equity
LBRDA
LBRDA
TOI
TOI
Q4 25
$-15.7M
Q3 25
$-12.3M
Q2 25
$10.4B
$-9.0M
Q1 25
$10.1B
$5.1M
Q4 24
$9.8B
$3.6M
Q3 24
$9.5B
$15.5M
Q2 24
$9.3B
$29.2M
Q1 24
$9.1B
$41.3M
Total Assets
LBRDA
LBRDA
TOI
TOI
Q4 25
$164.7M
Q3 25
$163.6M
Q2 25
$16.6B
$159.8M
Q1 25
$17.0B
$164.0M
Q4 24
$16.7B
$172.7M
Q3 24
$16.3B
$179.2M
Q2 24
$16.0B
$179.6M
Q1 24
$15.7B
$204.5M
Debt / Equity
LBRDA
LBRDA
TOI
TOI
Q4 25
Q3 25
Q2 25
0.30×
Q1 25
0.38×
Q4 24
0.38×
Q3 24
0.39×
Q2 24
0.39×
Q1 24
0.40×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LBRDA
LBRDA
TOI
TOI
Operating Cash FlowLast quarter
$91.0M
$3.2M
Free Cash FlowOCF − Capex
$37.0M
$2.2M
FCF MarginFCF / Revenue
14.2%
1.5%
Capex IntensityCapex / Revenue
20.7%
0.7%
Cash ConversionOCF / Net Profit
0.24×
TTM Free Cash FlowTrailing 4 quarters
$-49.0M
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LBRDA
LBRDA
TOI
TOI
Q4 25
$3.2M
Q3 25
$-12.6M
Q2 25
$91.0M
$-10.2M
Q1 25
$78.0M
$-5.0M
Q4 24
$1.0M
$4.2M
Q3 24
$24.0M
$819.0K
Q2 24
$27.0M
$-15.7M
Q1 24
$52.0M
$-15.9M
Free Cash Flow
LBRDA
LBRDA
TOI
TOI
Q4 25
$2.2M
Q3 25
$-13.2M
Q2 25
$37.0M
$-11.4M
Q1 25
$13.0M
$-5.3M
Q4 24
$-63.0M
$2.4M
Q3 24
$-36.0M
$417.0K
Q2 24
$-35.0M
$-17.5M
Q1 24
$-9.0M
$-16.5M
FCF Margin
LBRDA
LBRDA
TOI
TOI
Q4 25
1.5%
Q3 25
-9.7%
Q2 25
14.2%
-9.5%
Q1 25
4.9%
-5.1%
Q4 24
-24.0%
2.4%
Q3 24
-13.7%
0.4%
Q2 24
-14.2%
-17.7%
Q1 24
-3.7%
-17.4%
Capex Intensity
LBRDA
LBRDA
TOI
TOI
Q4 25
0.7%
Q3 25
0.4%
Q2 25
20.7%
1.0%
Q1 25
24.4%
0.3%
Q4 24
24.3%
1.8%
Q3 24
22.9%
0.4%
Q2 24
25.2%
1.9%
Q1 24
24.9%
0.6%
Cash Conversion
LBRDA
LBRDA
TOI
TOI
Q4 25
Q3 25
Q2 25
0.24×
Q1 25
0.29×
Q4 24
0.00×
Q3 24
0.17×
Q2 24
0.14×
Q1 24
0.22×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LBRDA
LBRDA

Segment breakdown not available.

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons